3D Tissue Models

This person is not registered. Is this you?


Profile Details
Michael Schmitz
Affiliations:

ETH

 
Zurich CH, 8093 Switzerland
Phone: +41 44 633 60 26
Fax:
My Blogs:
My Twitter Hashtags:
@von_Bruecken
 
Age:
Bio:
 
Specialty:
Cancer Immunotherapy
 
Presented at Events Covering:
 
Areas of Interest:
 
Hobbies:
 
General Comments:
BSN Rank: 42212 / 3501 (What's this?)
Accomplish Score: Unavailable
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 28
We'll Post Your CV for Free!
 
 
Speaking/Presenting-Abstract/Poster at Mtg: 0 (0 / 0)
 
Honors and Awards: 0 (0 / 0)
 
Clinical Trial Activity: 0 (0 / 0)
 
Grant Support: 0 (0 / 0)
 
Patents Pending: 0 (0 / 0)
 
Journal - Editor/Reviewer: 0 (0 / 0)
 
Peer Reviewed Papers, Books, Chapters: 1 (6 / 0)
  • Targeting the immune checkpoint receptors cytotoxic T lymphocyte antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1), or programmed cell death 1 ligand 1 (PD-L1) represents a very attractive treatment modality for tumor patients. ()
 
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
 
Membership in Professional Societies: 0 (0 / 0)
 
White Papers: 0 (0 / 0)
 
Registered on BiotechScienceNews: 0

About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.